Pulmonary cytokine composition differs in the setting of alcohol use disorders and cigarette smoking

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 304, Issue 12, 2013, Pages

  Burnham, Ellen L ^a   Kovacs, Elizabeth J ^b   Davis, Christopher S ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Interleukins; Pneumococcus; Pneumonia; Regulated and normal T cell expressed and secreted

Indexed keywords

CHEMOKINE; CYTOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GROWTH FACTOR; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; RANTES; VASCULOTROPIN;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; AMERICAN INDIAN; ARTICLE; BRONCHOSCOPY; CAUCASIAN; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HUMAN; LEUKOCYTE COUNT; LUNG ALVEOLUS CELL; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RACE DIFFERENCE; SMOKING; T LYMPHOCYTE; THORAX RADIOGRAPHY;

INTERLEUKINS; PNEUMOCOCCUS; PNEUMONIA; REGULATED AND NORMAL T CELL EXPRESSED AND SECRETED;

ADULT; AGE FACTORS; ALCOHOLISM; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CCL5; ETHANOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-12; INTERLEUKIN-1BETA; LUNG; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEX FACTORS; SMOKING; T-LYMPHOCYTES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84879143691     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00385.2012     Document Type: Article

References (70)

1. Abadie Y, Bregeon F, Papazian L, Lange F, Chailley-Heu B, Thomas P, Duvaldestin P, Adnot S, Maitre B, Delclaux C. Decreased VEGF concentration in lung tissue and vascular injury during ARDS. Eur Respir J 25: 139-146, 2005.
2. Albright JM, Davis CS, Bird MD, Ramirez L, Kim H, Burnham EL Gamelli RL, Kovacs EJ. The acute pulmonary inflammatory response to the graded severity of smoke inhalation injury. Crit Care Med 40: 1113-1121, 2012.
3. Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 167: 335-342, 2007.
4. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat 29: 1165-1188, 2001.
5. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284, 2001.
6. Bhatty M, Pruett SB, Swiatlo E, Nanduri B. Alcohol abuse and Streptococcus pneumoniae infections: consideration of virulence factors and impaired immune responses. Alcohol 45: 523-539, 2011.
7. Boe DM, Richens TR, Horstmann SA, Burnham EL, Janssen WJ Henson PM, Moss M, Vandivier RW. Acute and chronic alcohol exposure impair the phagocytosis of apoptotic cells and enhance the pulmonary inflammatory response. Alcohol Clin Exp Res 34: 1723-1732, 2010.
8. Braber S, Henricks PA, Nijkamp FP, Kraneveld AD, Folkerts G. Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation. Respir Res 11: 99, 2010.
9. Brown GP, Iwamoto GK, Monick MM, Hunninghake GW. Cigarette smoking decreases interleukin 1 release by human alveolar macrophages. Am J Physiol Cell Physiol 256: C260-C264, 1989.
10. Burnham EL, Gaydos J, Hess E, House R, Cooper J. Alcohol use disorders affect antimicrobial proteins and anti-pneumococcal activity in epithelial lining fluid obtained via bronchoalveolar lavage. Alcohol Alcohol 45: 414-421, 2010.
11. Burnham EL, Halkar R, Burks M, Moss M. The effects of alcohol abuse on pulmonary alveolar-capillary barrier function in humans. Alcohol Alcohol 44: 8-12, 2009.
12. Burnham EL, Phang TL, House R, Vandivier RW, Moss M, Gaydos J. Alveolar macrophage gene expression is altered in the setting of alcohol use disorders. Alcohol Clin Exp Res 35: 284-294, 2011.
13. Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S Qin L, Szabo G, Wheeler M, Zou J. Cytokines and alcohol. Alcohol Clin Exp Res 30: 720-730, 2006.
14. Das SK, Mukherjee S, Vasudevan DM. Effects of long term ethanol consumption mediated oxidative stress on neovessel generation in liver. Toxicol Mech Methods 22: 375-382, 2012.
15. Das SK, Varadhan S, Gupta G, Mukherjee S, Dhanya L, Rao DN Vasudevan DM. Time-dependent effects of ethanol on blood oxidative stress parameters and cytokines. Indian J Biochem Biophys 46: 116-121, 2009.
16. Davis CS, Albright JM, Carter SR, Ramirez L, Kim H, Gamelli RL Kovacs EJ. Early pulmonary immune hyporesponsiveness is associated with mortality after burn and smoke inhalation injury. J Burn Care Res 33: 26-35, 2012.
17. Detsky AS, Baker JP, Mendelson RA, Wolman SL, Wesson DE Jeejeebhoy KN. Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. JPEN J Parenter Enteral Nutr 8: 153-159, 1984.
18. Doz E, Noulin N, Boichot E, Guenon I, Fick L, Le BM, Lagente V Ryffel B, Schnyder B, Quesniaux VF, Couillin I. Cigarette smokeinduced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol 180: 1169-1178, 2008.
19. Epstein MA, Reynaldo S, El-Amin AN. Is smoking a risk factor for influenza hospitalization and death? J Infect Dis 201: 794-795, 2010.
20. Ergen AV, Boles NC, Goodell MA. Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing. Blood 119: 2500-2509, 2012.
21. Fillion I, Ouellet N, Simard M, Bergeron Y, Sato S, Bergeron MG. Role of chemokines and formyl peptides in pneumococcal pneumoniainduced monocyte/macrophage recruitment. J Immunol 166: 7353-7361, 2001.
22. Garcia-Vidal C, Ardanuy C, Tubau F, Viasus D, Dorca J, Linares J Gudiol F, Carratala J. Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. Thorax 65: 77-81, 2010.
23. Gu JW, Elam J, Sartin A, Li W, Roach R, Adair TH. Moderate levels of ethanol induce expression of vascular endothelial growth factor and stimulate angiogenesis. Am J Physiol Regul Integr Comp Physiol 281: R365-R372, 2001.
24. Hedlund J, Langer B, Konradsen HB, Ortqvist A. Negligible adjuvant effect for antibody responses and frequent adverse events associated with IL-12 treatment in humans vaccinated with pneumococcal polysaccharide. Vaccine 20: 164-169, 2001.
25. Hunninghake GW, Gadek JE, Kawanami O, Ferrans VJ, Crystal RG. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol 97: 149-206, 1979.
26. Jacups SP, Cheng A. The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia- over 22 years. Vaccine 29: 5386-5392, 2011.
27. Karimi R, Tornling G, Grunewald J, Eklund A, Skold CM. Cell recovery in bronchoalveolar lavage fluid in smokers is dependent on cumulative smoking history. PLoS One 7: e34232, 2012.
28. Koppe U, Suttorp N, Opitz B. Recognition of Streptococcus pneumoniae by the innate immune system. Cell Microbiol 14: 460-466, 2012.
29. Kosmider B, Messier EM, Chu HW, Mason RJ. Human alveolar epithelial cell injury induced by cigarette smoke. PLoS One 6: e26059, 2011.
30. Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med 166: 382-385, 2002.
31. Kuschner WG, D'Alessandro A, Wong H, Blanc PD. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 9: 1989-1994, 1996.
32. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR, Golenbock DT. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA 100: 1966-1971, 2003.
33. McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9: 349-351, 1989.
34. McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD. Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 150: 696-703, 1994.
35. Meyerholz DK, Edsen-Moore M, McGill J, Coleman RA, Cook RT Legge KL. Chronic alcohol consumption increases the severity of murine influenza virus infections. J Immunol 181: 641-648, 2008.
36. Neill DR, Fernandes VE, Wisby L, Haynes AR, Ferreira DM, Laher A, Strickland N, Gordon SB, Denny P, Kadioglu A, Andrew PW. T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice. PLoS Pathog 8: e1002660, 2012.
37. Neumann T, Neuner B, Gentilello LM, Weiss-Gerlach E, Mentz H Rettig JS, Schroder T, Wauer H, Muller C, Schutz M, Mann K, Siebert G, Dettling M, Muller JM, Kox WJ, Spies CD. Gender differences in the performance of a computerized version of the alcohol use disorders identification test in subcritically injured patients who are admitted to the emergency department. Alcohol Clin Exp Res 28: 1693-1701, 2004.
38. Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS, Breiman RF. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 342: 681-689, 2000.
39. Omidvari K, Casey R, Nelson S, Olariu R, Shellito JE. Alveolar macrophage release of tumor necrosis factor-alpha in chronic alcoholics without liver disease. Alcohol Clin Exp Res 22: 567-572, 1998.
40. Palaniappan R, Singh S, Singh UP, Singh R, Ades EW, Briles DE Hollingshead SK, Royal W 3rd, Sampson JS, Stiles JK, Taub DD, Lillard JW Jr. CCL5 modulates pneumococcal immunity and carriage. J Immunol 176: 2346-2356, 2006.
41. Perney P, Portales P, Clot J, Blanc F, Corbeau P. Diminished CD4+ T cell surface CCR5 expression in alcoholic patients. Alcohol Alcohol 39: 484-485, 2004.
42. Phipps JC, Aronoff DM, Curtis JL, Goel D, O'Brien E, Mancuso P. Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae. Infect Immun 78: 1214-1220, 2010.
43. Plevneshi A, Svoboda T, Armstrong I, Tyrrell GJ, Miranda A, Green K, Low D, McGeer A. Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto. PLoS One 4: e7255, 2009.
44. Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry C, Lonnroth K, Patra J, Poznyak V, Popova S. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health 9: 450, 2009.
45. Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. Alcohol Clin Exp Res 31: 185-199, 2007.
46. Rijneveld AW, Florquin S, Branger J, Speelman P, Van Deventer SJ, van der Poll T. TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia. J Immunol 167: 5240-5246, 2001.
47. Riquelme R, Jimenez P, Videla AJ, Lopez H, Chalmers J, Singanayagam A, Riquelme M, Peyrani P, Wiemken T, Arbo G, Benchetrit G Rioseco ML, Ayesu K, Klotchko A, Marzoratti L, Raya M, Figueroa S, Saavedra F, Pryluka D, Inzunza C, Torres A, Alvare P, Fernandez P, Barros M, Gomez Y, Contreras C, Rello J, Bordon J, Feldman C, Arnold F, Nakamatsu R, Riquelme J, Blasi F, Aliberti S, Cosentini R, Lopardo G, Gnoni M, Welte T, Saad M, Guardiola J, Ramirez J. Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia. Int J Tuberc Lung Dis 15: 542-546, 2011.
48. Robbins CS, Bauer CM, Vujicic N, Gaschler GJ, Lichty BD, Brown EG, Stampfli MR. Cigarette smoke impacts immune inflammatory responses to influenza in mice. Am J Respir Crit Care Med 174: 1342-1351, 2006.
49. Room R. Smoking and drinking as complementary behaviours. Biomed Pharmacother 58: 111-115, 2004.
50. Rubinsky AD, Kivlahan DR, Volk RJ, Maynard C, Bradley KA. Estimating risk of alcohol dependence using alcohol screening scores. Drug Alcohol Depend 108: 29-36, 2010.
51. Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med 352: 596-607, 2005.
52. Samokhvalov AV, Irving HM, Rehm J. Alcohol consumption as a risk factor for pneumonia: a systematic review and meta-analysis. Epidemiol Infect 138: 1789-1795, 2010.
53. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347: 669-671, 1990.
54. Schuckit MA. Alcohol-use disorders. Lancet 373: 492-501, 2009.
55. Shariatzadeh MR, Huang JQ, Tyrrell GJ, Johnson MM, Marrie TJ. Bacteremic pneumococcal pneumonia: a prospective study in Edmonton and neighboring municipalities. Medicine (Baltimore) 84: 147-161, 2005.
56. Srivastava A, Henneke P, Visintin A, Morse SC, Martin V, Watkins C Paton JC, Wessels MR, Golenbock DT, Malley R. The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease. Infect Immun 73: 6479-6487, 2005.
57. Standiford TJ, Danforth JM. Ethanol feeding inhibits proinflammatory cytokine expression from murine alveolar macrophages ex vivo. Alcohol Clin Exp Res 21: 1212-1217, 1997.
58. Strieter RM, Belperio JA, Keane MP. Host innate defenses in the lung: the role of cytokines. Curr Opin Infect Dis 16: 193-198, 2003.
59. Sun K, Salmon SL, Lotz SA, Metzger DW. Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect Immun 75: 1196-1202, 2007.
60. Suzuki M, Betsuyaku T, Nagai K, Fuke S, Nasuhara Y, Kaga K Kondo S, Hamamura I, Hata J, Takahashi H, Nishimura M. Decreased airway expression of vascular endothelial growth factor in cigarette smoke-induced emphysema in mice and COPD patients. Inhal Toxicol 20: 349-359, 2008.
61. Thaikoottathil JV, Martin RJ, Zdunek J, Weinberger A, Rino JG Chu HW. Cigarette smoke extract reduces VEGF in primary human airway epithelial cells. Eur Respir J 33: 835-843, 2009.
62. Thickett DR, Armstrong L, Millar AB. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med 166: 1332-1337, 2002.
63. van der Poll T, Keogh CV, Buurman WA, Lowry SF. Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med 155: 603-608, 1997.
64. van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374: 1543-1556, 2009.
65. Ward KA, Spokes PJ, McAnulty JM. Case-control study of risk factors for hospitalization caused by pandemic (H1N1) 2009. Emerg Infect Dis 17: 1409-1416, 2011.
66. Wilkosz S, Edwards LA, Bielsa S, Hyams C, Taylor A, Davies RJ Laurent GJ, Chambers RC, Brown JS, Lee YC. Characterization of a new mouse model of empyema and the mechanisms of pleural invasion by Streptococcus pneumoniae. Am J Respir Cell Mol Biol 46: 180-187, 2012.
67. Wright AK, Briles DE, Metzger DW, Gordon SB. Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection. Vaccine 26: 4893-4903, 2008.
68. Wright AK, Christopoulou I, El BS, Limer J, Gordon SB. rhIL-12 as adjuvant augments lung cell cytokine responses to pneumococcal whole cell antigen. Immunobiology 216: 1143-1147, 2011.
69. Yamaguchi E, Itoh A, Furuya K, Miyamoto H, Abe S, Kawakami Y. Release of tumor necrosis factor-alpha from human alveolar macrophages is decreased in smokers. Chest 103: 479-483, 1993.
70. Yeligar SM, Machida K, Tsukamoto H, Kalra VK. Ethanol augments RANTES/CCL5 expression in rat liver sinusoidal endothelial cells and human endothelial cells via activation of NF-kappa B, HIF-1 alpha, and AP-1. J Immunol 183: 5964-5976, 2009.